中原內配(002448.SZ):擬不超2.1億元在泰國投資新建生產基地
格隆匯1月2日丨中原內配(002448.SZ)公佈,為優化戰略佈局,增強市場競爭力,中原內配集團股份有限公司擬在泰國投資新建生產基地,踐行國家“一帶一路”倡議,同時也滿足公司未來業務發展和海外市場拓展的需要,該項目計劃投資金額不超過人民幣2.1億元,包括但不限於購買土地、購建固定資產等相關事項,實際投資金額以中國及當地主管部門批准金額為準。公司將根據市場需求和業務進展等具體情況分階段實施建設泰國生產基地,本次投資項目為公司主營業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.